The health of Victorians and Australians is set to improve with the announcement of significant Federal Government investment to support Advanced Health Research and Translation Centres. These leading Centres are accredited by the National Health and Medical Research Council to conduct rapid transformational research that delivers solutions to health service problems, with direct patient benefits.
An investment of AUD $10 million was announced yesterday by the Australian government. This investment will be initially focused across existing accredited Centres including Alfred Health and Monash Health and Partners (Monash Partners). Monash Partners directly integrates research, education and clinical care around a vision to improve the health of the community and encompasses Alfred Health, Monash Health, Baker Institute, Burnet Institute, Cabrini Health, Eastern Health, Epworth Healthcare, Hudson Institute, Monash University and Peninsula Health. Monash Partners will receive more than AUD $2 million as part of a formative investment to support world-leading research to underpin high-qualityhealth care improvement and better health outcomes.
Executive Director of Monash Partners, Professor Helena Teede, welcomed the Government’s support and leadership in this innovative initiative focusing on health service led, high impact research of direct importance to the community. She said these funds will support a wide range of translational research projects responsive directly to the needs of the communities, health providers and health services that will deliver direct clinical benefit.
Projects such as the Monash Partners Lung Cancer Care Improvement project addresses Australia’s number one cancer killer- lung cancer. With treatment options changing rapidly, here we will improve monitoring and quality of lung cancer care to ensure that all Victorians have access to the best possible, cutting-edge care, whether they are treated in our cities or regional and remote areas. This initiative will improve the care, health and quality of life for those with lung cancer.
“Using innovative approaches to address the biggest challenges currently facing health care provision in Victoria and Australia, Monash Partners represents a world leading, powerful collaboration between some of the best health researchers, leading clinicians and educators and the community who are both the funders and ultimate recipients of benefits from health and research investment,” Professor Teede said. “This important funding enables Monash Partners’ to collaboratively deliver consistent, high-quality healthcare for our communities, supported by world-leading research and an exceptional, well trained clinical workforce.”